Management of multifocal primary cutaneous CD30 anaplastic large cell lymphoma
- PMID: 15243534
- DOI: 10.1016/j.jaad.2003.12.028
Management of multifocal primary cutaneous CD30 anaplastic large cell lymphoma
Abstract
Primary cutaneous CD30(+) anaplastic large cell lymphoma in adults is rare, but the prognosis is generally excellent. Skin lesions may be localized or, less commonly, multifocal. Although not extensively reported, multifocal primary cutaneous anaplastic large cell lymphoma tends to relapse after systemic chemotherapy and is generally considered more prone to progress to extracutaneous involvement than the localized disease. We report the case of a 21-year-old woman with primary cutaneous CD30(+) anaplastic large cell lymphoma manifesting as widespread papules and nodules. Despite remaining localized to the skin, the disease relapsed after multiple chemotherapy regimens and autologous stem-cell transplantation. Treatment with an experimental anti-CD30 monoclonal antibody was successful. Review of this case and similar cases illustrates that traditional combination chemotherapy may not be best. Newer treatments, including anti-CD30 monoclonal antibodies, show promise. However, further study is needed to develop optimal therapeutic strategies.
Similar articles
-
Primary cutaneous CD30+ anaplastic large-cell lymphoma with generalized skin involvement and involvement of one peripheral lymph node, successfully treated with low-dose oral etoposide.Clin Exp Dermatol. 2009 Jul;34(5):e56-9. doi: 10.1111/j.1365-2230.2008.03182.x. Epub 2009 May 5. Clin Exp Dermatol. 2009. PMID: 19438576 Review.
-
Localized perineal cutaneous nodules: a case of recurrent systemic anaplastic large-cell lymphoma.Clin Exp Dermatol. 2009 Dec;34(8):e722-5. doi: 10.1111/j.1365-2230.2009.03448.x. Clin Exp Dermatol. 2009. PMID: 20055841
-
Successful treatment for recurrence of primary cutaneous anaplastic large-cell lymphoma in elderly patient with etoposide, mitoxantrone, cyclophosphamide, vincristine, prednisolone and bleomycin (VNCOP-B) therapy.J Dermatol. 2007 Aug;34(8):556-60. doi: 10.1111/j.1346-8138.2007.00330.x. J Dermatol. 2007. PMID: 17683387
-
[Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].Ai Zheng. 2006 Apr;25(4):486-9. Ai Zheng. 2006. PMID: 16613686 Chinese.
-
Myxoid variant of anaplastic large cell lymphoma involving the skin: a case report.J Cutan Pathol. 2012 Aug;39(8):787-90. doi: 10.1111/j.1600-0560.2012.01911.x. Epub 2012 May 22. J Cutan Pathol. 2012. PMID: 22612158 Review.
Cited by
-
ALK-negative primary cutaneous T-cell anaplastic large cell lymphoma, myxoid variant; masquerading as sarcoma: unveiling the diagnostic dilemma.BMJ Case Rep. 2021 Feb 5;14(2):e239350. doi: 10.1136/bcr-2020-239350. BMJ Case Rep. 2021. PMID: 33547131 Free PMC article.
-
CD30+ neoplasms of the skin.Curr Hematol Malig Rep. 2011 Dec;6(4):245-50. doi: 10.1007/s11899-011-0096-8. Curr Hematol Malig Rep. 2011. PMID: 21850406 Review.
-
Primary cutaneous anaplastic large cell lymphoma masquerading as large pyogenic granuloma.Indian Dermatol Online J. 2016 Nov-Dec;7(6):526-528. doi: 10.4103/2229-5178.193896. Indian Dermatol Online J. 2016. PMID: 27990392 Free PMC article.
-
Primary cutaneous CD 30+ anaplastic large cell lymphoma.Indian J Surg. 2010 Jul;72(Suppl 1):283-5. doi: 10.1007/s12262-010-0091-7. Epub 2010 Oct 20. Indian J Surg. 2010. PMID: 23133272 Free PMC article.
-
Breast implant-associated anaplastic large cell lymphoma: A review and assessment of cutaneous manifestations.Int J Womens Dermatol. 2017 Jul 11;3(3):140-144. doi: 10.1016/j.ijwd.2017.05.005. eCollection 2017 Sep. Int J Womens Dermatol. 2017. PMID: 28831423 Free PMC article.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical